Govt Approves Oxford Vaccine For India! Vaccination Starts For 30 Crore Indians By Jan 10th
In a big development, Indian Govt has now approved the vaccine being developed by Oxford University and AstraZeneca, for emergency usage in India.
This means that all Indians will be able to get the vaccine, called “Covishield”, and the 1st shot will be provided by January 10th.
Here are the details..
Oxford Vaccine Approved In India
Central Drugs Standard Control Organization (CDSCO) has approved the emergency usage of Covishield vaccine in India, which has been developed by Oxford and AstraZeneca, and being manufactured by Serum Institute in Pune.
The final approval by Drugs Controller General of India (DCGI) is being awaited, after which mass vaccination program will start to vaccinate 30 crore Indians in the 1st phase.
As per reports, the other vaccine developed by Bharat Biotech is still in the testing stage, and Govt has asked for more details regarding their vaccine before the approval.
This way, India has become the 3rd nation after UK and Argentina to approve the Oxford vaccine, which has reportedly exhibited a success rate of 90% in the clinical trials.
Rules For Vaccination
Govt has planned to vaccinate 30 crore Indians on priority, who are front-line workers, such as healthcare professionals, sanitation workers, policemen, and all Govt or private employees who are directly interacting and serving customers.
There will be extensive guidelines as well, such as:
- All the persons getting the vaccine will be provided with information about the vaccine
- The vaccinated person will be asked to report any adverse effect in every 15 days
- 2 doses will be provided, in a gap of 4-6 weeks
Serum Institute has pegged an approximate cost of Rs 200-225 per dose, and the expenses of the 1st 10 crore doses will be borne by PM Care fund.
As per the reports, the 1st shot of the vaccine can be given by January 10th.
We will keep you updated, as more details come in.